While the combination of pembrolizumab with standard-of-care (SOC) radiation, and androgen deprivation therapy (ADT) with or ...
Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...
The Oncology Nursing Society (ONS) is developing a skin of color toxicity photo repository with funding from a grant from La Roche-Posay to support oncology nurses in recognizing ...
Neoadjuvant EV plus pembrolizumab significantly improved event-free survival and overall survival vs gemcitabine/cisplatin in the phase 3 KEYNOTE-B15 trial. Neoadjuvant and adjuvant enfortumab vedotin ...
While every patient with cancer will have psychosocial needs, understanding when to assess those needs and what professionals to connect a patient with are key to supporting patie ...
Zongertinib has been granted accelerated approval in NSCLC harboring HER2 TKD mutations as part of the Commissioner’s ...